Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003011-46Phase 2Completed
Phase 2 trial of vitamin e, ascorbic acid and omega-3 fatty acid in coronary arteriosclerosis, sponsored by Dr. Olaf Stanger. Primary endpoint: Primary endpoint (pilot study). Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003011-46.